Most cited papers in Ocular Oncology and Treatments
What are the most cited papers in Ocular Oncology and Treatments?
The most cited paper in Ocular Oncology and Treatments is "Mutation and Cancer: Statistical Study of Retinoblastoma" (Alfred G. Knudson, 1971), with 7,700 citations. Next come "The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product" (3,072) and "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma" (2,994).
Showing 50 of 100 papers. Every paper with more than 574 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Mutation and Cancer: Statistical Study of Retinoblastoma Alfred G. Knudson · Proceedings of the National Academy of Sciences | Apr 1971 | 7,700 |
| 2 | The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product Nicholas J. Dyson, Peter M. Howley, Karl Münger et al. · Science | 17 Feb 1989 | 3,072 |
| 3 | A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Stephen Henry Friend, René Bernards, Snezna Rogelj et al. · Nature | Oct 1986 | 2,994 |
| 4 | Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Caroline Robert et al. · New England Journal of Medicine | 16 Nov 2014 | 2,718 |
| 5 | Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Keith T. Flaherty et al. · New England Journal of Medicine | 14 Jun 2012 | 2,179 |
| 6 | Expression of recessive alleles by chromosomal mechanisms in retinoblastoma Webster K. Cavenee, Thaddeus P. Dryja, Robert A. Phillips et al. · Nature | Oct 1983 | 1,953 |
| 7 | Effects of an Rb mutation in the mouse Tyler Jacks, Amin Fazeli, Earlene M. Schmitt et al. · Nature | Sep 1992 | 1,779 |
| 8 | The Molecular Genetics of Cancer J. Michael Bishop · Science | 16 Jan 1987 | 1,716 |
| 9 | The RB and p53 pathways in cancer Charles J. Sherr, Frank P. McCormick · Cancer Cell | Aug 2002 | 1,701 |
| 10 | The National Cancer Data Base report on cutaneous and noncutaneous melanoma Alfred E. Chang, Lucy Hynds Karnell, Herman R. Menck · Cancer | 15 Oct 1998 | 1,676 |
| 11 | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi Catherine D. Van Raamsdonk, Vladimir Bezrookove, Gary Green et al. · Nature | 10 Dec 2008 | 1,655 |
| 12 | Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas J. William Harbour, Michael D. Onken, Elisha D. O. Roberson et al. · Science | 4 Nov 2010 | 1,511 |
| 13 | Mutations in GNA11 in Uveal Melanoma Catherine D. Van Raamsdonk, Klaus Griewank, Michelle B. Crosby et al. · New England Journal of Medicine | 17 Nov 2010 | 1,503 |
| 14 | SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene James A. DeCaprio, John W. Ludlow, James Figge et al. · Cell | Jul 1988 | 1,488 |
| 15 | The E2F transcription factor is a cellular target for the RB protein Srikumar Chellappan, Scott W. Hiebert, Maria M. Mudryj et al. · Cell | Jun 1991 | 1,455 |
| 16 | Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence Wen‐Hwa Lee, Robert Bookstein, Frank Hong et al. · Science | 13 Mar 1987 | 1,438 |
| 17 | Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product Peter Whyte, Karen J. Buchkovich, Jonathan M. Horowitz et al. · Nature | Jul 1988 | 1,437 |
| 18 | Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma Mark B. Faries et al. · New England Journal of Medicine | 7 Jun 2017 | 1,415 |
| 19 | Uveal Melanoma: Trends in Incidence, Treatment, and Survival Arun D. Singh, Mary E. Turell, Allan K. Topham · Ophthalmology | 28 Jun 2011 | 1,286 |
| 20 | Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006) Jacob Schachter, Antoni Ribas, Georgina Venetia Long et al. · The Lancet | 16 Aug 2017 | 1,256 |
| 21 | p53: A Frequent Target for Genetic Abnormalities in Lung Cancer Takashi Takahashi, Marion M. Nau, Itsuo Chiba et al. · Science | 27 Oct 1989 | 1,232 |
| 22 | The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole Jay S. Duker, Peter K. Kaiser, Susanne Binder et al. · Ophthalmology | 17 Sep 2013 | 1,203 |
| 23 | The Rb/E2F pathway: expanding roles and emerging paradigms J. William Harbour, Douglas C. Dean · Genes & Development | Oct 2000 | 1,178 |
| 24 | The Five-year Incidence and Progression of Age-related Maculopathy Ronald Klein, Ronald Klein, Susan C. Jensen et al. · Ophthalmology | 1997 | 1,138 |
| 25 | Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes Ante S. Lundberg, Robert A. Weinberg · Molecular and Cellular Biology | Feb 1998 | 1,078 |
| 26 | Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma Emma Kujala, Teemu Ma¨kitie, Tero Kivelä · Investigative Ophthalmology & Visual Science | 24 Oct 2003 | 1,064 |
| 27 | Survey of 1264 patients with orbital tumors and simulating lesions Jerry A. Shields, Carol L. Shields, Richard Scartozzi · Ophthalmology | May 2004 | 1,052 |
| 28 | Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Mark E. Ewen, Hayla K. Sluss, Charles J. Sherr et al. · Cell | May 1993 | 1,034 |
| 29 | Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma Genevieve Schindler, David Capper, Jochen Meyer et al. · Acta Neuropathologica | 28 Jan 2011 | 1,033 |
| 30 | The retinoblastoma protein is phosphorylated during specific phases of the cell cycle Karen J. Buchkovich, Linda Duffy, Ed Harlow · Cell | 22 Sep 1989 | 1,029 |
| 31 | Requirement for a functional Rb-1 gene in murine development Alan Richard Clarke, Els Robanus Maandag, M van Roon et al. · Nature | Sep 1992 | 1,015 |
| 32 | Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Philip W. Hinds, Sibylle Mittnacht, Vjekoslav Dulić et al. · Cell | Sep 1992 | 1,014 |
| 33 | Non-syndromic retinitis pigmentosa Sanne K. Verbakel, Ramon A. C. van Huet, Camiel J. F. Boon et al. · Progress in Retinal and Eye Research | 27 Mar 2018 | 1,011 |
| 34 | Survey of 520 Eyes with Uveal Metastases Carol L. Shields, Jerry A. Shields, Nicole Groß et al. · Ophthalmology | Aug 1997 | 1,008 |
| 35 | The international incidence of childhood cancer D M Parkin, Charles A. Stiller, Gerald J. Draper et al. · International Journal of Cancer | 15 Oct 1988 | 1,003 |
| 36 | Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts David A. Alcorta, Yue Xiong, Dawn E. Phelps et al. · Proceedings of the National Academy of Sciences | 26 Nov 1996 | 994 |
| 37 | Cellular mechanisms of tumour suppression by the retinoblastoma gene Deborah L. Burkhart, Julien Sage · Nature reviews. Cancer | 24 Jul 2008 | 989 |
| 38 | Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation Phang‐Lang Chen, Peter Scully, Jin‐Yuh Shew et al. · Cell | Sep 1989 | 983 |
| 39 | Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas David Jones, Sylvia Kocialkowski, Lu Liu et al. · Cancer Research | 30 Oct 2008 | 958 |
| 40 | Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma A. Gordon Robertson et al. · Cancer Cell | Aug 2017 | 932 |
| 41 | The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element James A. DeCaprio, John W. Ludlow, Dennis C. Lynch et al. · Cell | 22 Sep 1989 | 928 |
| 42 | p14ARF links the tumour suppressors RB and p53 Stewart Bates, Andrew C. Phillips, Paula A. Clark et al. · Nature | Sep 1998 | 922 |
| 43 | Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC J. William Harbour, Shinn-Liang Lai, Jacqueline Whang‐Peng et al. · Science | 15 Jul 1988 | 919 |
| 44 | Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma Paul Nathan et al. · New England Journal of Medicine | 22 Sep 2021 | 916 |
| 45 | Frequency of TERT promoter mutations in human cancers João Vinagre et al. · Nature Communications | 26 Jul 2013 | 913 |
| 46 | TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION Michael A. Gimbrone, Stephen B. Leapman, Ramzi S. Cotran et al. · The Journal of Experimental Medicine | Aug 1972 | 907 |
| 47 | Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Jiri Lukas, David A.D. Parry, Louise Aagaard et al. · Nature | Jun 1995 | 904 |
| 48 | Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes Zofia Michalewska, Janusz Michalewski, Ron Afshari Adelman et al. · Ophthalmology | 12 Jun 2010 | 869 |
| 49 | Uveal melanoma Martine Johanna Jager, Carol L. Shields, Colleen M. Cebulla et al. · Nature Reviews Disease Primers | 9 Apr 2020 | 867 |
| 50 | Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting M. Vestergaard, Petra Macaskill, Phoebe E Holt et al. · British Journal of Dermatology | Jun 2008 | 867 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.